Nature5 年
Balancing B-cell subsets in EAE
Rituximab, a CD20-specific monoclonal antibody that depletes B cells, has shown promising results in patients with relapsing-remitting multiple sclerosis. Studies of experimental autoimmune ...
Venetoclax could improve outcomes of CAR T therapy for patients with resistant B-cell lymphomas
About a third of patients with diffuse large B cell lymphoma (DLBCL), a fast-growing form of lymphoma, will see their disease ...
Medscape15 天
POLARIX: Extended Results Confirm Standard of Care for DLBCL
The 5-year results of the POLARIX study show a continued progression-free survival benefit for patients with diffuse large ...
GlobalData on MSN9 天
BrightPath and Cellistic partner for clinical trial advancements of CAR-T cell therapy
BrightPath Bio and Cellistic have entered a process development and manufacturing agreement to progress the allogeneic CAR-T ...